Performance and comparison of Healing Responses After Treatment of Complex Bifurcation Lesions With the AXXESS Biolimus Eluting Stent with AbsorbTM everolimus-eluting Stents: an Optical Coherence Tomography Analysis.

Trial Profile

Performance and comparison of Healing Responses After Treatment of Complex Bifurcation Lesions With the AXXESS Biolimus Eluting Stent with AbsorbTM everolimus-eluting Stents: an Optical Coherence Tomography Analysis.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Apr 2017

At a glance

  • Drugs Everolimus (Primary) ; Umirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms COBRA II
  • Most Recent Events

    • 08 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top